<DOC>
	<DOCNO>NCT01696799</DOCNO>
	<brief_summary>To compare pharmacokinetics Econazole Nitrate Foam Econazole Nitrate Cream subject interdigital tinea pedis age 12 year less 18 year .</brief_summary>
	<brief_title>Comparative PK Study Econazole Nitrate Foam Econazole Nitrate Cream Subjects With Interdigital Tinea Pedis Aged 12 Years Less Than 18 Years</brief_title>
	<detailed_description>Based result previous clinical study evaluate pharmacokinetics , safety efficacy EN Foam versus reference list econazole nitrate cream foam vehicle adult , current clinical study conduct provide additional pharmacokinetic data EN foam formulation subject age 12 less 18 year interdigital tinea pedis support clinical bridge systemic safety RLD pediatric population . The study also include clinical safety endpoint .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Econazole</mesh_term>
	<criteria>Be 12 year less 18 year age either sex . Have clinical diagnosis interdigital tinea pedis Parent/guardian provide write informed consent subject provide write assent . Be willing able use assign study medication direct commit followup visit duration study . Have microscopic evidence ( positive KOH ) presence fungi positive fungal culture . Be good health free disease physical condition might , Investigator 's opinion , expose subject unacceptable risk study participation . Females must nonpregnant , nonlactating intend become pregnant course study . Is pregnant , nurse plan pregnancy study Has use topical antifungal topical corticosteroid foot within 14 day prior start study . Has receive systemic antifungal therapy within 12 week prior start study medication . Has use systemic antibacterial systemic corticosteroid within 14 day prior start study . Has history uncontrolled diabetes mellitus immunocompromised ( due disease , e.g. , HIV , medication ) . Has concurrent moccasintype tinea pedis ( opinion Investigator ) . Has skin disease might interfere evaluation tinea pedis . Is currently enrol investigational drug device study . Has receive investigational drug treatment investigational device within 30 day prior enter study . Is unreliable , include subject history drug alcohol abuse . Has know hypersensitivity component study medication .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>